Concepedia

Farzan Rastinejad

FR

Statistics

Publications

13

Citations

3.5K

H-Index

13

Active since

1989

Affiliations

Pfizer (United States)(Current)

Stanford University

University of Pennsylvania

Howard Hughes Medical Institute

Northwestern University

Farzan Rastinejad is an author at Pfizer (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1989–2003

13

Publications

13

A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Deborah J. Good, Peter J. Polverini, Farzan Rastinejad et al. · Proceedings of the National Academy of Sciences · 1990 · 1.1K citations · Full text

, , +17

Pharmacological Rescue of Mutant p53 Conformation and Function

Barbara A. Foster, Heather A. Coffey, Michael J. Morin et al. · Science · 1999 · 799 citations

, , +17

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene

Farzan Rastinejad, Peter J. Polverini, Noël Bouck · Cell · 1989 · 470 citations

, , +8

Genetic complementation reveals a novel regulatory role for 3? untranslated regions in growth and differentiation

Farzan Rastinejad · Cell · 1993 · 245 citations

, , +11

Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin

Farzan Rastinejad, Michael J. Conboy, Thomas A. Rando et al. · Cell · 1993 · 201 citations

1–5 of 13